INTRODUCTION
============

Lim and his coworkers [@B001]-[@B003] have found that all of total ginseng saponin (TGS), panaxadiol and panaxatriol cause the increased secretion of catecholamines (CA) from the isolated perfused rabbit adrenal glands in a Ca^2+^ -dependent fashion, which are mediated by the activation of cholinergic (both nicotinic and muscarinic) receptors and partly the direct action on the rabbit adrenomedullary chromaffin cells. However, it has been reported that TGS shows the inhibitory effect on the CA release evoked by stimulation of nicotinic receptors in the perfused rat adrenal medulla [@B004], and also that several ginseng saponins (ginsenosides) from the ginseng root inhibit the CA secretion from bovine adrenal chromaffin cells stimulated by acetylcholine (ACh) [@B005]-[@B008].

Moreover, it has been known that ginsenosides or ginseng extracts cause the hypotensive action [@B009]-[@B013] while they can rather produces the hypertensive action [@B014]-[@B017]. TGS is found to produce the pressor and depressor actions in the anesthetized normotensive rats [@B018].

Furthermore, ginseng, when given at small dose in spontaneously hypertensive rat (SHR), causes pressor response, but at relatively large dose rather produces dose-dependent hypotensive response with decreased plasma renin activity [@B019]-[@B021]. Sokabe and his coworkers [@B022] have shown that administration of Korean Red ginseng powder for 11 weeks has no effect on blood pressure in normotensive Donryu rats, SHR and renal hypertensive rats, whereas it elevates slightly blood pressure in deoxycorticosterone salt hypertensive rats. Recently, it has also been reported that long-term use of North American ginseng had no effect on 24-hour blood pressure and renal function in hypertensive individuals [@B023].

In the conscious rats, the releasing effect of nitric oxide (NO) of Korean red ginseng (KRG) may be partly contributed to the hypotensive effect of KRG [@B011]. It has also been shown that Rg~3~ relaxes the rat thoracic aorta as a consequence of NO production [@B024]. Han and his co-workers [@B025] have found evidence that NO levels in exhaled breath of human volunteers by KRG were increased along with decreased blood pressure and heart rate. In a series of studies, it has been found that ginsenosides reduce blood pressure via increases in production of endothelial nitric oxide [@B009] and that Rg~3~ is the most potent ginsenoside that activates endothelial nitric oxide synthase (eNOS) in rat aorta [@B026]. Although some investigators have demonstrated that Rg~3~ induces eNOS activation in the vasculature of animal models [@B009],[@B027], Hien and his co-workers [@B028] have found that Rg~3~ activates eNOS via eNOS phosphorylation in ECV 304 human endothelial cells and increases in eNOS expression.

Several studies have shown that ginsenoside Rg~1~ can cause endothelial-dependent relaxation in the rat aorta [@B027] and enhance endogenous NO production in human umbilical vein endothelial cells [@B029], rat kidney [@B030] and in porcine coronary arteries [@B031].

Despite of these many studies, there is still controversy about the functional effects of TGS on the cardiovascular system, especially blood pressure and adrenal CA secretion. Therefore, the aim of the present study was to investigate the ability of TGS on the CA secretion in the perfused model of SHR's adrenal gland, and to establish its mechanism of action.

MATERIALS AND METHODS
=====================

Experimental procedure
----------------------

Mature male spontaneously hypertensive rats with reference systolic blood pressure of 178±6 mmHg (purchased from Damool Science, Seoul, Korea), weighing 200 to 300 grams, were used in the experiment. The animals were housed individually in separate cages, and food (Cheil Animal Chow, Formula M07^®^, Feedlab, Gyeonggi Province, Korea) and tap water were allowed *ad libitum* for at least a week to adapt to experimental circumstances. On the day of experiment, a rat was anesthetized with thiopental sodium (50 mg/kg) intraperitoneally, and tied in supine position on fixing panel.

Isolation of adrenal glands
---------------------------

The adrenal gland was isolated by the modification of previous method [@B032]. The abdomen was opened by a midline incision, and the left adrenal gland and surrounding area were exposed by the placement of three-hook retractors. The stomach, intestine and portion of the liver were not removed, but pushed over to the right side and covered by saline-soaked gauge pads and urine in bladder was removed in order to obtain enough working space for tying blood vessels and cannulations. A cannula, used for perfusion of the adrenal gland, was inserted into the distal end of the renal vein after all branches of adrenal vein (if any), vena cava and aorta were ligated. Heparin (400 IU/mL) was injected into *vena cava* to prevent blood coagulation before ligating vessels and cannulations. A small slit was made into the adrenal cortex just opposite entrance of adrenal vein. Perfusion of the gland was started, making sure that no leakage was present, and the perfusion fluid escaped only from the slit made in adrenal cortex. Then the adrenal gland, along with ligated blood vessels and the cannula, was carefully removed from the animal and placed on a platform of a leucite chamber. The chamber was continuously circulated with water heated at 37±1℃ ([Fig. 1](#F001){ref-type="fig"}).

Perfusion of adrenal gland
--------------------------

The adrenal glands were perfused by means of peristaltic pump (ISCO, Lincoln, NE, USA) at a rate of 0.31 mL/ min. The perfusion was carried out with Krebs-bicarbonate solution of following composition (mM): NaCl, 118.4; potassium chloride (KCl), 4.7; CaCl~2~, 2.5; MgCl~2~, 1.18; NaHCO~3~, 25; KH~2~PO~4~, 1.2; glucose, 11.7. The solution was constantly bubbled with 95% O~2~+ 5% CO~2~ and the final pH of the solution was maintained at 7.4 to 7.5. The solution contained disodium EDTA (10 μg/mL) and ascorbic acid (100 μg/mL) to prevent oxidation of catecholamines.

Drug administration
-------------------

The perfusions of 1.1-dimethyl-4 -phenyl piperazinium iodide (DMPP, 100 μM) for 2 min and/or a single injection of ACh (5.32 mM) and KCl (56 mM) in a volume of 0.05 mL were made into perfusion stream via a three-way stopcock, respectively. 3-(m-chloro-phenyl-carbamoyl-oxy)-2-butynyl- trimethyl ammonium chloride (McN-A-343, 100 μM), veratridine (100 μM), methyl-1, 4-dihydro-2,6-dimethyl- 3-nitro-4-(2-trifluoro-methyl-phenyl)-pyridine-5-carboxylate (Bay-K-8644, 10 μM) and cyclopiazonic acid (10 μM) were also perfused for 4 min, respectively.

In the preliminary experiments, it was found that upon administration of the above drugs, secretory responses to ACh, KCl, McN-A-343, Bay-K-8644 and cyclopiazonic acid returned to preinjection level in about 4 min, but the responses to DMPP in 8 min.

Collection of perfusate
-----------------------

As a rule, prior to stimulation with various secretagogues, the perfusate was collected for 4 min to determine the spontaneous secretion of CA (background sample). Immediately after the collection of the background sample, collection of the perfusates was continued in another tube as soon as the perfusion medium containing the stimulatory agent reached the adrenal gland. Stimulated sample's perfusate was collected for 4 to 8 min. The amounts secreted in the background sample have been subtracted from that secreted from the stimulated sample to obtain the net secretion value of CA, which is shown in all of the figures.

To study the effect of TGS on the spontaneous and evoked secretion, the adrenal gland was perfused with normal Krebs solution for 90 min, and then the perfusate was collected for a certain period (background sample). Then the medium was changed to the one containing the stimulating agent or along with TGS, and the perfusates were collected for the same period as that for the background sample. The adrenal gland's perfusate was collected in chilled tubes.

Measurement of catecholamines
-----------------------------

The content of CA (all of epinephrine, norepinephrine and dopamine) in perfusate was measured directly by the fluorometric method of Anton and Sayre [@B033] without the intermediate purification alumina for the reasons described earlier [@B032] using fluorospectrophotometer (Kontron Co., Milano, Italy).

A volume of 0.2 mL of the perfusate was used for the reaction. The CA content in the perfusate of stimulated glands by secretagogues used in the present work was high enough to obtain readings several folds greater than the reading of control samples (unstimulated). The sample blanks were also lowest for perfusates of stimulated and non-stimulated samples. The CA content in the perfusate was expressed in terms of norepinephrine (base) equivalents.

Measurement of nitric oxide release
-----------------------------------

NO release was measured using a NO-selective microelectrode (ami700; Innovative Instruments Inc., Tampa, FL, USA) and an amplifier (inNo meter, Innovative Instruments Inc.). Adrenomedullary NO production was quantified as the integrated signal detected by the microelectrode after perfusion of TGS into adrenal medulla of SHRs, as previously described [@B034]. The electrode was calibrated by producing standardized concentrations of NO in 0.5% (wt/vol) KI in 0.1 mol/L H~2~SO~4~ from NaNO~2~ standards. NO release was quantitated as the current detected at the electrode after loading TGS into adrenal medulla. NO release was calculated as picomoles.

Statistical analysis
--------------------

The statistical difference between the control and the pretreated groups was determined by the Student's t-test and ANOVA test. A *p*-value of less than 0.05 was considered to represent statistically significant changes unless specifically noted in the text. Values given in the text refer to means and the standard errors of the mean. The statistical analysis of the experimental results was made by computer program described by Tallarida and Murray [@B035].

Drugs and their sources
-----------------------

The following drugs were used: 1.1-dimethyl-4 -phenyl piperazinium iodide (DMPP), acetylcholine chloride, norepinephrine bitartrate, potassium chloride (KCl), N^ω^-nitro-L-arginine methyl ester hydrochloride (ʟ-NAME), methyl-1,4-dihydro-2,6-dimethyl-3-nitro-4-(2-trifluoro-methyl-phenyl)-pyridine-5-carboxylate (BAY-K-8644), cyclopiazonic acid, potassium nitrate (Sigma Chemical Co., St Louis, MO, USA), veratridine and 3-(m-cholro-phenyl-carbamoyl-oxy)-2-butynyl-trimethyl ammonium chloride \[McN-A-343\] (RBI, Natick, MA, USA). total ginseng saponin were a gift from late Dr. Young-Ho Kim (Professor of Sejong University, Seoul, Korea). Drugs were dissolved in distilled water (stock) and added to the normal Krebs solution as required except Bay-K-8644, which was dissolved in 99.5% ethanol and diluted appropriately with Krebs-bicarbonate solution (final concentration of alcohol was less than 0.1%). Concentrations of all drugs except TGS used were expressed in terms of molar base.

RESULTS
=======

Effects of TGS on the CA secretion evoked by ACh, high K^+^, DMPP and McN-A-343 from the perfused adrenal glands of the SHRs
----------------------------------------------------------------------------------------------------------------------------

After the perfusion with oxygenated Krebs-bicarbonate solution for 1 h, basal CA release from the isolated perfused rat adrenal glands amounted to 21±2 ng for 2 min (*n*=10). Since, it has been found that ginseng saponins cause the increased CA secretion from the isolated perfused rabbit adrenal glands [@B001]-[@B003] while rather inhibited the CA secretion in rat adrenal gland [@B004] and in bovine adrenal chromaffin cells [@B005],[@B006],[@B008],[@B036], it was attempted initially to examine the effects of TGS itself on CA secretion from the perfused model of the adrenal glands of the SHRs. However, in the present study, TGS (15-150 μg/mL) itself did not produce any effect on basal CA output from the perfused rat adrenal glands (data not shown). Therefore, it was decided to investigate the effects of TGS on cholinergic receptor stimulation- as well as membrane depolarization-evoked CA secretion. Secretagogues were given at 15 to 20 min-intervals. TGS was present for 90 minutes after the establishment of the control release.

![Dose-dependent effects of saponin total ginseng (TGS) on the secretory responses of CA evoked by acetylcholine (A) and high potassium (B) from the perfused rat adrenal medulla. The CA secretion by a single injection of ACh (5.32 mM) and K^+^ (56 mM) in a volume of 0.05 mL was evoked at 15 min intervals during loading with 15, 50 and 150 μg/mL of TGS for 90 min as indicated by the arrow marks, respectively. The numbers in parentheses indicate the number of rat adrenal glands. Vertical bars on the columns represent the standard error of the mean±SEM. Ordinate: the amounts of CA secreted from the adrenal gland (% of control). Abscissa: collection time of perfusate (min). Statistical difference was obtained by comparing the corresponding control with each concentration-treated group of TGS. ACh- and high K+-induced perfusates were collected for 4 minutes, respectively. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g001){#F001}

When ACh (5.32 mM) in a volume of 0.05 mL was injected into the perfusion stream, the amount of CA secreted was 1493±32 ng for 4 min. However, the pretreatment with TGS in the range of 15-150 μg/mL for 90 min relatively concentration- and time-dependently inhibited ACh-stimulated CA secretion. As shown in [Fig. 1](#F001){ref-type="fig"}A, in the presence of TGS, the CA releasing responses were inhibited to 68% of the corresponding control release (100%). Also, it has been found that depolarizing agent like KCl stimulates markedly CA secretion (752±27 ng for 0-4 min). High K^+^ (5.6 mM)-stimulated CA secretion after the pretreatment with 15 μg/mL TGS was not affected for the first 45 min period as compared with its corresponding control secretion ([Fig. 1](#F001){ref-type="fig"}B).

However, following the pretreatment with higher concentrations of TGS (50-150 μg/mL), high K^+^ (56 mM)-stimulated CA secretion was maximally inhibited to 63% of the control after 75 min period, although it was not initially affected at 50 μg/mL of TGS. DMPP (100 μM), which is a selective nicotinic receptor agonist in autonomic sympathetic ganglia, evoked a sharp and rapid increase in CA secretion (1392±38 ng for 0-8 min). However, as shown in [Fig. 2](#F002){ref-type="fig"}A, DMPP-stimulated CA secretion after the pretreatment with TGS (50 μg/mL) was greatly reduced to 80% of the control release. As shown in [Fig. 2](#F002){ref-type="fig"}B, McN-A-343 (10 μM), which is a selective muscarinic M1-agonist [@B037], perfused into an adrenal gland for 4 min caused an increased CA secretion (683±27 ng for 0-4 min). However, McN-A-343-stimulated CA secretion in the presence of TGS (50 μg/mL) was markedly depressed to 78% of the corresponding control secretion (100%).

![Time-course effects of TGS on the CA secretory responses evoked by DMPP (A) and McN-A-343 (B) from the perfused rat adrenal medulla. The CA secretion by perfusion of DMPP (100 μM) for 2 min and McN-A-343 (100 μM) for 4 min was induced at 20 and 15 min intervals during loading with 50 μg/mL of TGS for 90 min, respectively. DMPP- and McN-A-343-induced perfusates were collected for 8 and 4 minutes, respectively. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g002){#F002}

Effects of TGS on the CA secretion evoked by Bay-K-8644, cyclopiazonic acid and veratridine from the perfused adrenal glands of the SHRs
----------------------------------------------------------------------------------------------------------------------------------------

Since Bay-K-8644 is known to be a calcium channel activator, which enhances basal Ca^2+^ uptake [@B038] and CA release [@B039], it was of interest to determine the effects of TGS on Bay-K-8644-stimulated CA secretion from the isolated perfused rat adrenal glands. Bay-K-8644 (10 μM)-stimulated CA secretion in the presence of TGS (50 μg/mL) was reduced to 79% of the control except for the early 15 min period as compared to the corresponding control release (608±22 ng for 0-4 min) from 8 adrenal glands of SHRs, as shown in [Fig. 3](#F003){ref-type="fig"}A.

![Time-course effects of TGS on the CA secretion evoked by Bay-K-8644 (A) and cyclopiazonic acid (B) from the perfused rat adrenal medulla. Bay-K-8644 (10 μM) and cyclopiazonic acid (10 μM) were perfused into an adrenal vein for 4 min at 15 min intervals during loading with TGS (50 μg/mL) for 90 min. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g003){#F003}

Cyclopiazonic acid, a mycotoxin from *Aspergillus* and *Penicillium*, has been described as a highly selective inhibitor of Ca^2+^-ATPase in skeletal muscle sarcoplasmic reticulum [@B040],[@B041]. The inhibitory action of TGS on cyclopiazonic acid-evoked CA secretory response was observed as shown in [Fig. 3](#F003){ref-type="fig"}B. However, in the presence of TGS (50 μg/mL) in 8 adrenal glands of SHRs, cyclopiazonic acid (10^-5^M)-evoked CA secretion was also inhibited to 78% of the control response (576±24 ng for 0-4 min).

![Time-course effects of TGS on veratridine-evoked CA secretion from the perfused rat adrenal medulla. Veratridine (50 μM) was perfused into an adrenal vein for 4 min at 15 min intervals during loading with TGS (50 μg/mL) for 90 min. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g004){#F004}

It has been known that veratridine-induced Na^+^ influx mediated through voltage-dependent Na^+^ channels increased Ca^2+^ influx via activation of voltage-dependent Ca^2+^ channels and produced the exocytotic CA secretion in cultured bovine adrenal medullary cells [@B042]. As shown in [Fig. 4](#F004){ref-type="fig"}, veratridine (5× 10^-5^ M) sharply produced CA secretion (725± 27 ng for 0-4 min). TGS (50 μ g/ mL) also attenuated veratridine-induced CA secretion to 68% of the corresponding control release in a time-dependent manner.

Effects of TGS plus ʟ-NAME on the CA release evoked by ACh, high K^+^, DMPP and McN-A-343 from the perfused adrenal glands of the SHRs
--------------------------------------------------------------------------------------------------------------------------------------

It has also been found that, in this study, TGS inhibited the CA secretory response evoked by cholinergic stimulation in the perfused adrenal glands of SHRs. Therefore, to study the relationship between NO and TGS-induced inhibitory effects on the CA release from the adrenal glands of SHRs, the effect of ʟ-NAME on TGS-induced inhibitory responses of CA secretion evoked by cholinergic receptor-stimulation as well as membrane depolarization was examined.

In the present study, in the simultaneous presence of TGS (50 μg/mL) and ʟ-NAME (30 μM) for 90 min from 6 adrenal glands of SHRs, ACh (5.32 mM)-evoked CA release was initially not affected at first 4 min, but later rather recovered to 92% of the corresponding control release at the period of 90-94 min compared to that of TGS (50 μg/mL)-treated group only, as illustrated in [Fig. 5](#F005){ref-type="fig"}A. High K^+^ (56 mM)-evoked CA release in the presence of TGS (50 μg/mL) and ʟ-NAME (30 μM) for 90 min was also not changed for 0-64 min, and then recovered to 92% of the corresponding control release at the last period of 90 to 94 min period in comparison to that of TGS (50 μg/mL)-treated group only from 8 glands ([Fig. 5](#F005){ref-type="fig"}B).

![Effects of TGS plus ʟ-NAME on the CA secretory responses evoked by acetylcholine (A) and high potassium (B) from the perfused rat adrenal medulla. The CA secretion by a single injection of ACh (5.32 mM) and K^+^ (56 mM) in a volume of 0.05 mL was evoked at 15 min intervals during simultaneous loading with TGS (50 μg/mL) plus ʟ-NAME (30 μM) for 90 min. Statistical difference was obtained by comparing the corresponding control with TGS-treated group or group treated with TGS+ʟ-NAME. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g005){#F005}

As shown in [Fig. 6](#F006){ref-type="fig"}A, the simultaneous perfusion of TGS and ʟ-NAME for 90 min no longer inhibited DMPP-evoked CA release for the period of 0-68 min from 6 adrenal glands while later rather recovered to 95% of the control release at the period of 80-88 min. Moreover, in the simultaneous presence of TGS and ʟ-NAME for 90 min, McN-A-343-evoked CA secretory responses was also time-dependently recovered to 95% 0f the control secretion compared to that of TGS (50 μg/mL)-treated group only from 8 glands as shown in [Fig. 6](#F006){ref-type="fig"}B, although they were not affected at period of 0-64 min.

![Effects of TGS plus ʟ-NAME on the CA secretory responses evoked by DMPP (A) and McN-A-343 (B) from the perfused rat adrenal medulla. The CA secretion by perfusion of DPPP (100 μM) for 2 min and McN-A-343 (100 μM) for 4 min was induced at 20 and 15 min intervals after preloading with TGS (50 μg/mL) plus ʟ-NAME (30 μM) for 90 min, respectively. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"} and [5](#F005){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g006){#F006}

Effects of TGS plus ʟ-NAME on the CA release evoked by BAY-K-8644, cyclopiazonic acid and veratridine from the perfused adrenal glands of the SHRs
--------------------------------------------------------------------------------------------------------------------------------------------------

As shown in [Fig. 7](#F007){ref-type="fig"}A, the simultaneous perfusion of TGS (50 μg/mL) and ʟ-NAME (30 μM) for 90 min no longer inhibited the CA release evoked by Bay-K-8644 for the period of 0-64 min from 8 glands, and then also recovered to 92% of the control release at the last period of 90-94 min in comparison to that of TGS (50 μg/mL)-treated group only. As shown in [Fig. 7](#F007){ref-type="fig"}B, in the presence of TGS (50 μg/mL) and ʟ-NAME (30 μM) for 90 min in 6 rat adrenal glands, cyclopiazonic acid (10^-5^ M)-evoked CA secretion was recovered to 90% of the control response (100%) at the period of 90 to 94 min in comparison to that of TGS (60 μg/mL)-treated group only. Also, the simultaneous perfusion of TGS (50 μg/mL) and ʟ-NAME (30 μM) for 90 min no longer reduced the veratridine-evoked CA release for the period of 0 to 64 min from 8 glands, and then finally recovered to 86% of the control release at the last period of 90 to 94 min in comparison to that of TGS (50 μg/mL)-treated group only ([Fig. 8](#F008){ref-type="fig"}).

![Effects of TGS plus ʟ-NAME on the CA secretory responses evoked by Bay-K-8644 (A) and cyclopiazonic acid (B) from the perfused rat adrenal medulla. Bay-K-8644 (10 μM) and cyclopiazonic acid (10 μM) were perfused into an adrenal vein for 4 min at 15 min intervals during simultaneous loading with TGS (50 μg/mL) plus ʟ-NAME (30 μM) for 90 min. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"} and [5](#F005){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g007){#F007}

![Effects of TGS plus ʟ-NAME on veratridine-evoked CA secretory responses from the perfused rat adrenal medulla. Veratridine (50 μM) was perfused into an adrenal vein for 4 min at 15 min intervals during simultaneous loading with TGS (50 μg/mL) plus ʟ-NAME (30 μM) for 90 min. Other legends are the same as in [Fig. 1](#F001){ref-type="fig"} and [5](#F005){ref-type="fig"}. ns, not statistically significant. \**p*\<0.05, \*\**p*\<0.01.](grosbr-35-176-g008){#F008}

Effect of TGS on the level of nitric oxide released from the perfused adrenal medulla of the SHRs
-------------------------------------------------------------------------------------------------

As shown in [Figs. 5](#F005){ref-type="fig"}-[8](#F008){ref-type="fig"}, the inhibitory effects of TGS on cholinergic stimulation- and direct membrane depolarization-evoked CA secretory responses were significantly reduced in the presence of ʟ-NAME. Therefore, it was decided directly to determine the level of NO released from adrenal medulla of SHRs after the treatment of TGS. Moreover, it has been found that ginsenosides reduce blood pressure via increases in production of endothelial nitric oxide [@B009] and that ginsenoside Rg~3~ is the most potent ginsenoside that activates eNOS in rat aorta [@B026]. Although some investigators have demonstrated that Rg~3~ induces eNOS activation in the vasculature of animal models [@B009],[@B027].

In 10 adrenal glands, the basal amount of NO released from medulla prior to administration of TGS was 14.8±2 picomoles. However, 8 min after loading with TGS (150 μg/mL) it was greatly elevated to 27.0±3 pM, which was 182% of the basal release, as shown in [Fig. 9](#F009){ref-type="fig"}.

![Effects of TGS on nitric oxide (NO) production in the perfused rat adrenal medulla. Perfusate sample was taken for 8 min after loading the perfusion of TGS (150 μg/mL) at a rate of 0.31 mL/min. Ordinate: the amounts of NO released from the adrenal medulla (% of control). Abscissa: treatment (before and after TGS). Statistical difference was made by comparing the control with TGS-treated group. \*\**p*\<0.01.](grosbr-35-176-g009){#F009}

DISCUSSION
==========

The present experimental results have suggested that TGS inhibits the CA secretory responses from the isolated perfused adrenal gland of the SHRs evoked by stimulation of cholinergic (both muscarinic and nicotinic) receptors as well as by direct membrane-depolarization. It seems that this inhibitory effect of TGS is exerted by inhibiting influx of both Na^+^ and Ca^2+^ ions into the adrenomedullary chromaffin cells of the SHRs and also by suppression of Ca^2+^ release from the cytoplasmic calcium store at least partly through the activation of NO production, which is relevant to the blockade of neuronal nicotinic receptors.

In the present study, in the simultaneous presence of TGS and ʟ-NAME (NO synthase inhibitor), the CA secretory responses evoked by ACh, high K^+^, DMPP, McN-A-343, Bay-K-8644, cyclopiazonic acid, and veratridine were considerably recovered to the extent of the corresponding control secretion compared to those of TGS treatment alone. This result is well consistent with the report that, in a series of studies, ginsenosides reduce blood pressure via increases in production of endothelial nitric oxide [@B009] and that ginsenoside Rg~3~ is the most potent ginsenoside that activates eNOS in rat aorta [@B026]. Although several investigators have demonstrated that Rg~3~ induces eNOS activation in the vasculature of animal models [@B009],[@B027], Hien and his co-workers [@B028] have found that Rg~3~ activates eNOS via eNOS phosphorylation in ECV 304 human endothelial cells and increases in eNOS expression. Moreover, in this study, following treatment of TGS into adrenal medulla of SHRs, NO production was greatly elevated as shown in [Fig. 9](#F009){ref-type="fig"}. Taking into account these findings, in the present study, it is likely that TGS inhibits the CA secretory response evoked by various secretagogues through increasing NO production in adrenal chromaffin cells since TGS-induced inhibitory responses of CA secretion were significantly reduced in the presence of ʟ-NAME, an inhibitor of NO synthase, and TGS practically enhanced NO release from adrenal medulla of SHRs.

In support of this idea, several studies have shown that ginsenoside Rg~1~ can cause endothelial-dependent relaxation in the rat aorta [@B027] and enhance endogenous NO production in human umbilical vein endothelial cells [@B029], rat kidney [@B030] and in porcine coronary arteries [@B031]. Nitric oxide has been implicated in many actions of ginseng [@B043], including the ability of ginseng and ginsenosides to relax rabbit pulmonary [@B044] and monkey cerebral arteries [@B045], decrease neuronal ischemia [@B046], and inhibit stress-induced glucocorticoid secretion in mice [@B047].

Some studies have demonstrated antioxidant actions of the crude extract of the *Panax ginseng* (GE), and those related to NO synthesis and release [@B043]. Chen and Lee [@B048] reported that GE potentiated the relaxant response to electrical nerve stimulation of isolated rabbit *corpus cavernosum*. Such a neurogenic response in a variety of vasculature, including the cerebral artery [@B049], and *corpus cavernosum* [@B050] is mediated by NO liberated from autonomic efferent nerves that belongs to the parasympathetic nervous system and is called 'nitroxidergic' [@B051]. This inhibitory nerve is recognized to play important roles in the regulation of cerebrovascular resistance and cerebral blood flow [@B052] and intracavernous pressure/penile erection [@B053]. Based on these reports, the results of the present study indicate that TGS can inhibit the CA release evoked by cholinergic stimulation and membrane depolarization from the adrenal medulla of SHRs at least by the increased NO production due to activation of neuronal nitric oxide synthase, since this inhibitory effect of TGS on the CA secretory responses was significantly attenuated in the presence of ʟ-NAME, an inhibitor of nitric oxide synthase, and TGS actually enhanced NO release from the perfused adrenal medulla.

In support of this idea, generally, NO is produced enzymatically from the terminal guanidino nitrogen of L-arginine by the action of NOS [@B054],[@B055]. There are at least three isoforms of NOS: neuronal NOS (nNOS), eNOS, and inducible NOS. The adrenal medulla possesses characteristic postganglionic sympathetic neurons, and the presence of nNOS has been demonstrated [@B056]-[@B059]. In vitro studies using NOS inhibitors and NO donors were performed to examine the role of NO in modulating CA secretion from the adrenal medulla but the results remain controversial. In the present work, in presence of ʟ-NAME, the inhibitory responses of TGS on the CA secretion were recovered to the considerable extent of the control secretion compared with the inhibitory effects of TGS-treatment alone. This result indicates that TGS can inhibit the CA release at least partly through the activation of nNOS in the adrenal medulla of SHRs. In the support of this finding, it has been reported that the NOS inhibitor, ʟ-NAME enhances K^+^-stimulated CA secretion in cultured bovine chromaffin cells [@B060] and that sodium nitroprusside (SNP) inhibits ACh-induced CA secretion in bovine chromaffin cells [@B061]. These studies suggest that NO may play an inhibitory role in the control of the CA secretion. Moreover, the presence of endothelial cells has been reported to inhibit the K^+^-induced or the nicotinic receptor agonist DMPP-induced CA secretion in cultured bovine chromaffin cells [@B060], suggesting that not merely nNOS but also eNOS may play roles in modulating adrenal CA secretion. In view of the results so far reported, the present studies strongly suggest that TGS possesses the ability partly to activate nNOS in the adrenomedullary chromaffin cells of SHRs, resulting in enhancement of NO as well as inhibition of the CA release, in addition to the direct inhibitory effects on the CA secretion. In supporting this finding, among the ginsenosides of the protopanaxatriol and protopanaxadiol groups, ginsenoside Rg~3~ is the most potent vasodilator. Previously, it was shown that Rg~3~ inhibited calcium-induced vascular contraction [@B026] as well as phenylephrine-induced vasocontraction as a consequence of NO production [@B024]. Recently, it is known that ginsenoside Re also releases NO via a membrane sex steroid receptors, resulting in activation of large-conductance Ca^2+^-activated K^+^ channels (K/Ca channels) in vascular smooth muscle cells, promoting vasodilatation and preventing severe arterial contraction [@B062]. Furthermore, it has been proposed in an earlier report with monkey cerebral arteries that prejunctional muscarinic receptors of M~2~ subtype contribute to an inhibition by neurogenic ACh of nitroxidergic nerve function [@B063]. Therefore, in the present study, the ability of TGS to inhibit McN-A-343-evoked CA release supports the possible involvement of muscarinic receptor blockade in the increased release of NO.

In contrast, it has been reported that ʟ-NAME inhibits ACh-induced CA secretion in bovine chromaffin cells [@B064], and that the NO donor SNP enhances nicotine-induced CA secretion in cultured bovine chromaffin cells [@B065]. These findings suggest that NO may facilitate cholinergic agonist-induced CA secretion. On the other hand, a few in vivo studies have suggested that NO does not play a role in regulation of adrenal CA secretion [@B066],[@B067].

Generally, the adrenal medulla has been employed as a model system to study numerous cellular functions involving not only noradrenergic nerve cells but also neurons. During neurogenic stimulation of the adrenal medulla, ACh is released from splanchnic nerve endings and activates cholinergic receptors on the chromaffin cell membrane [@B068]. This activation initiates a series of events known as stimulus-secretion coupling, culminating in the exocytotic release of CA and other components of the secretory vesicles into the extracellular space. Usually, two mechanisms are involved in the secretion of adrenal medullary hormones. Upon excitation of splanchnic nerves, ACh is released from the nerve terminals, and then activates nicotinic the CA secretion. Based on this fact, the present findings that TGS inhibited the CA secretory responses evoked by nicotinic receptor stimulation as well as by membrane depolarization in the adrenal medulla of SHRs seem to support the fact that, ginsenosides from *Panax ginseng* can decrease the blood pressure in both experimental animals and hypertensive patients [@B009],[@B010],[@B012],[@B013]. These experimental results indicate that TGS-induced inhibitory activity of the CA secretory response evoked by stimulation of nicotinic receptors might contribute at least partly to its hypotensive mechanism. ACh, the physiological presynaptic transmitter at the adrenal medulla, which is released by depolarizing splanchnic nerve terminals and then activates nicotinic receptors, releases the CA, and induces dopamine β-hydroxylase by calcium-dependent secretory process [@B069],[@B070]. In terms of this fact, the present results suggest that TGS may inhibit CA secretion evoked by nicotinic stimulation from the splanchnic nerve ending through the blockade of nicotinic receptors. The CA release from the adrenal medulla in response to splanchnic nerve stimulation or nicotinic agonist is mediated by activation of nicotinic receptors located on the chromaffin cells. The exocytotic CA release from the chromaffin cells appears to be essentially similar to that occurring in noradrenergic axons [@B071],[@B072]. ACh-evoked CA secretion has shown to be caused through stimulation of both nicotinic and muscarinic receptors in guinea-pig adrenal gland [@B073] as well as in the perfused rat adrenal glands [@B074]. In support of this idea, it has been found that the ginseng saponins, ginsenoside Rg~2~, a panaxatriol [@B006] as well as ginsenoside Rg~3~, a panaxadiol [@B008] block the nicotinic ACh receptors or the receptor-operated Na^+^ channels (but not voltage-sensitive Na^+^ and Ca^2+^ channels), inhibit Na^+^ influx through the channels and consequently reduce both Ca^2+^ influx and the CA secretion in bovine adrenal chromaffin cells.

In this study, TGS inhibited the CA secretory responses evoked by ACh, high K^+^, DMPP, and McN-A-343. It suggests that TGS can produce the similar effect as in adrenal medulla of the normotensive rats [@B004] and also in bovine adrenal chromaffin cells [@B006],[@B008]. In previous study, ginsenoside-Rg~3~ inhibited both ACh-induced Ca^2+^ and Na^+^ influxes in a concentration-dependent manner similar to that observed with the ACh-evoked CA secretion [@B008]. However, it had no or only a slight effect on the CA secretion and Ca^2+^ influx induced by high K^+^ concentration or veratridine, an activator of the voltage-sensitive Ca^2+^ or Na^+^ channels [@B005],[@B006]. These results strongly suggested that ginsenoside-Rg~3~ acts on the nicotinic ACh receptor-operated cation channels but not on the voltage-sensitive Ca^2+^ or Na^+^ channels. Furthermore, the ginsenoside-Rg~3~ inhibition was not overcome by increasing the external ACh and Ca^2+^ concentrations [@B008], indicating that the inhibitory effect of ginsenoside-Rg~3~ is distinct from that of the competitive antagonists of the nicotinic ACh receptors, such as trimethaphan [@B075],[@B076], and that of blockers of the L-type voltage-sensitive Ca^2+^ channels, which are competitive with external Ca^2+^ concentrations, such as diltiazem [@B077]. In fact, the mode of the ginsenoside-Rg~3~ antagonism was non-competitive with nicotine [@B008]. Anyway, these results seem to be quite different from those of the present study that TGS significantly inhibited the CA secretory responses evoked by cholinergic stimulation as well as an activator of the voltage-sensitive Ca^2+^ or Na^+^ channels in the perfused model of SHR's adrenal medulla. The discrepancy is due to the experimental employment of different accounting methodology and different components between the present and previous studies.

In the present study, TGS also time-dependently depressed the CA secretory response evoked by Bay-K-8644, which is known to activate L-type voltage-dependent Ca^2+^ channels [@B038],[@B078]. This result indicates that TGS may inhibit Ca^2+^ influx to the adrenomedullary cells of SHRs. In support of this idea, in cultured bovine adrenal medullary cells, nicotinic (but not muscarinic) receptors mediate the Ca^2+^-dependent CA secretion [@B079],[@B080]. It has also been known that the activation of nicotinic receptors stimulates the CA secretion by increasing Ca^2+^ entry through receptor-linked and/or voltage-dependent Ca^2+^ channels in both perfused rat adrenal glands [@B074],[@B081] and isolated bovine adrenal chromaffin cells [@B082]-[@B084]. Wada and his coworkers [@B085] have found that the adrenomedullary chromaffin cells have 1) nicotinic receptor-associated ionic channels, responsible for carbachol-induced Na^+^ influx, 2) voltage-dependent Na^+^ channels, responsible for veratridine-induced Na^+^ influx and 3) voltage-dependent Ca^2+^ channels (VDCC), suggesting that the influx of Na^+^ caused either by carbachol or by veratridine leads to activate voltage-dependent Ca^2+^ channels by altering membrane potentials, whereas high K^+^ directly activates voltage-dependent Ca^2+^ channels without increasing Na^+^ influx. In the present study, the finding that the CA secretory responses evoked by Bay-k-8644 as well as by high K^+^ were depressed in the presence of TGS indicates that this inhibitory effect of TGS is exerted by the direct inhibition of calcium influx through VDCC into the adrenal chromaffin cells of SHRs. Furthermore, slight elevation in the extracellular potassium concentration increases both the frequency of spontaneous action potentials and the CA secretion [@B086], suggesting that the influx of calcium that occurs during action potentials is directly linked to the rate of secretion. These findings that TGS inhibited the CA secretion evoked by Bay-K-8644 as well as by high K^+^ suggest that TGS can inhibit directly the VDCC. In the bovine chromaffin cells, stimulation of nicotinic, but not muscarinic ACh receptors is known to cause CA secretion by increasing Ca^2+^ influx largely through VDCC [@B087],[@B088]. Therefore, it seems that these inhibitory effects of TGS on the CA secretion evoked by ACh, DMPP and veratridine may be mediated by inhibiting Ca^2+^ influx through voltage-dependent Ca^2+^ channels due to activation of nicotinic receptor-associated ionic channels, responsible for carbachol-induced Na^+^ influx, as well as of voltage-dependent Na^+^ channels, responsible for veratridine-induced Na^+^ influx.

The present study has also shown that TGS inhibits the CA secretion evoked by cyclopiazonic acid. Cyclopiazonic acid is known to be a highly selective inhibitor of Ca^2+^-ATPase in skeletal muscle sarcoplasmic reticulum [@B040],[@B041] and a valuable pharmacological tool for investigating intracellular Ca^2+^ mobilization and ionic currents regulated by intracellular Ca^2+^ [@B089]. Therefore, it is felt that the inhibitory effect of TGS on the CA secretion may also be associated with the mobilization of intracellular Ca^2+^ from the cytoplasmic calcium store. This indicates that the TGS can inhibit the release of Ca^2+^ from the intracellular pools induced by stimulation of muscarinic ACh receptors, which is weakly responsible for the CA secretion. It has been shown that Ca^2+^-uptake into intracellular storage sites susceptible to caffeine [@B090] is almost completely abolished by treatment with cyclopiazonic acid during the proceeding of Ca^2+^ load [@B089]. This is consistent with the findings obtained in skinned smooth muscle fibers of the longitudinal layer of the guinea-pig ileum, where Ca^2+^-uptake was also inhibited by cylopiazonic acid [@B091]. Suzuki and his coworkers [@B089] have shown that cyclopiazonic acid easily penetrates into the cytoplasm through the plasma membrane and reduces Ca^2+^-ATPase activity in sarcoplasmic/endoplasmic reticulum, resulting in an increase in the subsequent Ca^2+^ release from those storage sites. Moreover, in bovine adrenal chromaffin cells, stimulation of muscarinic ACh receptors is also proposed to cause activation of phosphoinositide metabolism, resulting in the formation of inositol 1,4,5-trisphosphate, which induces the mobilization of Ca^2+^ from the intracellular pools [@B092],[@B093]. The present results suggest that TGS-induced depression of the CA secretion evoked by McN-A-343 and cyclopiazonic acid may be due to the inhibition of Ca^2+^ release from the intracellular pools induced by stimulation of muscarinic ACh receptors. However, in the present study, it is uncertain whether the inhibitory effect of TGS on Ca^2+^ movement from intracellular pools is due to its direct effect on the PI response or the indirect effects.

In conclusion, the results of the present study have strongly suggested that TGS inhibits the CA secretion by stimulation of cholinergic nicotinic receptors as well as by direct membrane depolarization in the isolated perfused adrenal glands of SHRs. It seems that this inhibitory effect of TGS is exerted by blocking influx of sodium and calcium through ionic channels into the adrenomedullary chromaffin cells of SHRs as well as by inhibiting the release of Ca^2+^ from the cytoplasmic calcium store at least partly via the increased NO production due to the activation of nitric oxide synthase. Based on these results, the ingestion of TGS may be helpful to prevent or alleviate the cardiovascular diseases, through inhibition of CA secretion from adrenomedullary chromaffin cells and consequent reduction of the CA level in the circulation.
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